Non-Hodgkin's lymphoma (NHL) is a type of cancer that affects the lymphatic system, which is a part of the body's immune system. It is characterized by the abnormal growth of lymphocytes, a type of white blood cell, in the lymph nodes and other lymphoid tissues. NHL is a broad term that encompasses various subtypes of lymphoma, each with its own characteristics and treatment options.
The exact cause of NHL is unknown, but certain risk factors such as age, weakened immune system, exposure to certain chemicals or radiation, and certain infections have been associated with its development. Common symptoms include swollen lymph nodes, fever, night sweats, fatigue, and unexplained weight loss.
Diagnosis of NHL involves a combination of physical examination, imaging tests, and biopsy of the affected lymph nodes or tissues. Treatment options depend on the subtype and stage of the lymphoma but may include chemotherapy, radiation therapy, immunotherapy, targeted therapy, or stem cell transplantation.
Early detection and prompt treatment can significantly improve the prognosis for NHL patients. Regular follow-up care is essential to monitor the response to treatment and manage any potential side effects or complications.